Graft injury in relation to graft size in right lobe live donor liver transplantation: a study of hepatic sinusoidal injury in correlation with portal hemodynamics and intragraft gene expression

scientific article

Graft injury in relation to graft size in right lobe live donor liver transplantation: a study of hepatic sinusoidal injury in correlation with portal hemodynamics and intragraft gene expression is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/00000658-200302000-00015
P698PubMed publication ID12560784

P2093author name stringSheung-Tat Fan
John Wong
Ting-Bo Liang
Irene Oi-Lin Ng
Terence Kin-Wah Lee
Kwan Man
Chi-Leung Liu
Chung-Mau Lo
Zhi-Wei Zhang
Peter Chin-Wan Fung
Steven Hung-Teng Tsui
P2860cites workSmall graft for living donor liver transplantationQ28362695
A novel potent vasoconstrictor peptide produced by vascular endothelial cellsQ29620540
Study of donor-recipient liver size match for transplantationQ30466933
Renal proliferative arteriopathies and associated glomerular changes: a light and electron microscopic studyQ33504792
Role of microcirculation in hepatic ischemia/reperfusion injury.Q33702470
Lessons from genetically engineered animal models. IV. Nitric oxide synthase gene knockout miceQ33749161
Endogenous nitric oxide synthesis: biological functions and pathophysiologyQ33814359
Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injuryQ33902524
A formula to estimate the approximate surface area if height and weight be known. 1916.Q34437560
Nitric oxide modulation of focal adhesions in endothelial cellsQ40949467
Hsp70 chaperone systems: diversity of cellular functions and mechanism of actionQ41752367
Protective effect of heat preconditioning of rat liver graft resulting in improved transplant survivalQ43605133
Bosentan, an endothelin antagonist, augments hepatic graft function by reducing graft circulatory impairment following ischemia/reperfusion injuryQ43613012
Heme oxygenase-1 protects against vascular constriction and proliferationQ43625670
Functional analysis of grafts from living donors. Implications for the treatment of older recipients.Q46664890
Small-for-size grafts in living-related liver transplantationQ47214528
Liver transplantation in rats using small-for-size grafts: a study of hemodynamic and morphological changesQ47216526
Impact of graft size mismatching on graft prognosis in liver transplantation from living donorsQ47271534
A correlated study of the fine structure and physiology of the perfused rat liverQ47889240
Calculation of child and adult standard liver volume for liver transplantation.Q52342275
Adult-to-Adult Living Donor Liver Transplantation Using Extended Right Lobe GraftsQ58236287
MINIMUM GRAFT VOLUME FOR SUCCESSFUL ADULT-TO-ADULT LIVING DONOR LIVER TRANSPLANTATION FOR FULMINANT HEPATIC FAILUREQ58236334
Endothelin-1 is involved in the pathogenesis of ischemia/reperfusion liver injury by hepatic microcirculatory disturbancesQ72271861
Evidence that portal vein decompression improves survival of canine quarter orthotopic liver transplantationQ72287867
Endothelin-1 induces direct constriction of hepatic sinusoidsQ72411025
Technical refinement in adult-to-adult living donor liver transplantation using right lobe graftQ73355906
A protective player in the vascular response to injuryQ73954816
The effects of splenic artery ligation in an experimental model of secondary hypersplenismQ73956773
Prior induction of heat shock proteins by a nitric oxide donor attenuates cardiac ischemia/reperfusion injury in the ratQ74052942
Plasma nitric oxide is associated with the occurrence of moderate to severe acute graft-versus-host disease in haemopoietic stem cell transplant recipientsQ74452983
Somatostatin suppresses endothelin-1-induced rat hepatic stellate cell contraction via somatostatin receptor subtype 1Q74631271
Patterns of vasoregulatory gene expression in the liver response to ischemia/reperfusion and endotoxemiaQ77212324
Ischemia/reperfusion induces an increase in the hepatic portal vasoconstrictive response to endothelin-1Q77827403
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectliver transplantationQ1368191
hemodynamicsQ1642137
P304page(s)256-264
P577publication date2003-02-01
P1433published inAnnals of SurgeryQ4767866
P1476titleGraft injury in relation to graft size in right lobe live donor liver transplantation: a study of hepatic sinusoidal injury in correlation with portal hemodynamics and intragraft gene expression
P478volume237

Reverse relations

cites work (P2860)
Q36523507Application of Induced Pluripotent Stem Cells in Liver Diseases
Q38438725Assessment of right liver graft perfusion effectiveness between one and two-catheter infusion methods
Q45016019Attenuation of small-for-size liver graft injury by FTY720: significance of cell-survival Akt signaling pathway.
Q36111140Can living donor liver transplantation offer similar outcomes to deceased donor liver transplantation using expanded selection criteria for hepatocellular carcinoma?
Q37145514Cellular liver regeneration after extended hepatic resection in pigs
Q40644081Clinical analysis of patients with hepatocellular carcinoma recurrence after living-donor liver transplantation
Q55037451Clinical implication of hepatic volumetry for living donor liver transplantation.
Q50002580Comparison of Regeneration of Remnant Liver After Hemihepatectomy with or Without the Middle Hepatic Vein
Q36926615Deceased-donor split-liver transplantation in adult recipients: is the learning curve over?
Q47371856Determinants of hospital mortality of adult recipients of right lobe live donor liver transplantation
Q36123284Dual-Purpose Bioreactors to Monitor Noninvasive Physical and Biochemical Markers of Kidney and Liver Scaffold Recellularization
Q33421276Dysfunction in Patients With Small-for-Size Grafts After Living Donor Liver Transplantation.
Q41817590Early Graft Dysfunction in Living Donor Liver Transplantation and the Small for Size Syndrome
Q37362874Early graft dysfunction following adult-to-adult living-related liver transplantation: predictive factors and outcomes.
Q46731329Effect of the portacaval shunt on reperfusion injury after 65% hepatectomy in pigs.
Q33719955Effects of heme oxygenase-1-modified bone marrow mesenchymal stem cells on microcirculation and energy metabolism following liver transplantation
Q58570352Efficacy of Sorafenib for the Treatment of Post-Transplant Hepatocellular Carcinoma Recurrence
Q41688113Establishing a Porcine Model of Small for Size Syndrome following Liver Resection
Q90661851Evaluation of the role of transhepatic flow in postoperative outcomes following major hepatectomy (THEFLOW): study protocol for a single-centre, non-interventional cohort study
Q47300684FK 409 ameliorates small-for-size liver graft injury by attenuation of portal hypertension and down-regulation of Egr-1 pathway.
Q45214556FTY720 attenuates hepatic ischemia-reperfusion injury in normal and cirrhotic livers.
Q47114724Glutathione Peroxidase 3 Delivered by hiPSC-MSCs Ameliorated Hepatic IR Injury via Inhibition of Hepatic Senescence
Q34405116Gut-liver axis improves with meloxicam treatment after cirrhotic liver resection
Q46967688Hepatocyte dynamics in a three-dimensional rotating bioreactor
Q40136744Historical perspective of living donor liver transplantation
Q26766049Impact of non-oncological factors on tumor recurrence after liver transplantation in hepatocellular carcinoma patients
Q37366919Influence of portosystemic shunt on liver regeneration after hepatic resection in pigs
Q33212247Ischemic preconditioning impairs liver regeneration in extended reduced-size livers
Q57066918Liver Transplantation for Hepatitis B Virus-related Hepatocellular Carcinoma in Hong Kong
Q38168828Liver function impairment in liver transplantation and after extended hepatectomy
Q61045905Liver transplantation for hepatocellular carcinoma
Q28073940Liver transplantation for hepatocellular carcinoma from living-donor vs. deceased donor
Q88979476Living donor liver transplantation for hepatocellular cancer: an (almost) exclusive Eastern procedure?
Q44669532Living donor liver transplantation with special reference to ABO-incompatible grafts and small-for-size grafts
Q89953527Living vs. deceased-donor liver transplantation for patients with hepatocellular carcinoma
Q79925691Living-donor right hepatectomy with or without inclusion of middle hepatic vein: comparison of morbidity and outcome in 56 patients
Q34263346Living-donor vs deceased-donor liver transplantation for patients with hepatocellular carcinoma
Q26997063Management of recurrent hepatocellular carcinoma after liver transplant
Q46739710Maximizing venous outflow after right hepatic living donor liver transplantation with a venous graft patch.
Q43540063Portal inflow and pressure changes in right liver living donor liver transplantation including the middle hepatic vein
Q64328743Portal venous pressure and proper graft function in living donor liver transplants in 69 patients from an Egyptian center
Q34601591Posterior cavoplasty: a new approach to avoid venous outflow obstruction and symptoms for small-for-size syndrome in right lobe living donor liver transplantation
Q37280357Pretreatment of Small-for-Size Grafts In Vivo by γ -Aminobutyric Acid Receptor Regulation against Oxidative Stress-Induced Injury in Rat Split Orthotopic Liver Transplantation
Q24309608Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation
Q47308949Protective effect of adenosine A2A receptor activation in small-for-size liver transplantation
Q37823542Regulation of hepatic blood flow: the hepatic arterial buffer response revisited
Q38125626Review of the surgical approach to prevent small-for-size syndrome in recipients after left lobe adult LDLT.
Q36889221Role of reactive metabolites of oxygen and nitrogen in partial liver transplantation: lessons learned from reduced-size liver ischaemia and reperfusion injury
Q46728701Safety limit of the extent of hepatectomy for rats with moderately fatty liver: experimental study concerning living liver donor safety
Q34977062Scoring selection criteria including total tumour volume and pretransplant percentage of lymphocytes to predict recurrence of hepatocellular carcinoma after liver transplantation
Q34563749Sequential transcatheter arterial chemoembolization and portal vein embolization for hepatocellular carcinoma: the university of Tokyo experience
Q53588822Significance of CT attenuation value in liver grafts following right lobe living-donor liver transplantation.
Q42395923Small-for-size syndrome in adult-to-adult living-related liver transplantation
Q38217423Small-for-size syndrome in living-donor liver transplantation using a left lobe graft
Q46920608Splenic artery ligation ameliorates hepatic ischemia and reperfusion injury in rats
Q42168904Splenic artery ligation improves remnant liver function in partially hepatectomized rats with ischemia/reperfusion injury
Q47262575Successful treatment of small-for-size syndrome in adult-to-adult living-related liver transplantation: single center series
Q38700048The Impact of Liver Graft Injury on Cancer Recurrence Posttransplantation
Q40123406The significance of proline-rich tyrosine kinase2 (Pyk2) on hepatocellular carcinoma progression and recurrence.
Q82104029[Small-for-size: experimental findings for liver surgery]

Search more.